GlassScriptPhysician profile
Audrey Rostov
NPI 1427057512
$154,683.20
in general payments reported to CMS, 2019-2025
29 companies · $17K in 2025
The $17K reported for 2025 was more than what 96% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $13K · 2021: $30K · 2022: $32K · 2023: $17K · 2024: $14K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $16K · Food and Beverage: $6,487 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $650 · Travel and Lodging: $79.40 · Gift: $36.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,905.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $16,325.00 |
| Food and Beverage | $6,487.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $650.00 |
| Travel and Lodging | $79.40 |
| Gift | $36.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $35,000.83 | 2019-2025 | Visumax, Veracity Surgical, Mel 90 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $31,455.56 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $22,922.70 | 2022-2025 | Miebo, Xiidra, Blink Nutritears |
| Rxsight INC | $18,442.78 | 2021-2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Lensar, INC. | $17,621.27 | 2019-2025 | Lensar Laser System |
| Kala Pharmaceuticals, INC. | $7,482.19 | 2019-2021 | |
| Carl Zeiss Meditec USA, INC. | $5,610.40 | 2021-2025 | Visumax, Mel 90, Cirrus Hd-Oct |
| Glaukos Corporation | $2,986.19 | 2020-2025 | Istent Inject Trabecular Micro-Bypass System Model G2-M-Is, Kxl System (Not Refurbished), Photrexa Viscous and Photrexa |
| Johnson & Johnson Surgical Vision, INC. | $2,528.19 | 2022-2025 | Amo Phaco Needle |
| Microsurgical Technology, INC. | $2,000.00 | 2024 | |
| Dompe US, INC. | $1,856.25 | 2019-2025 | Oxervate |
| Allergan, INC. | $1,559.72 | 2019-2022 | |
| Thea Pharma INC. | $915.11 | 2022-2025 | |
| Shire North American Group INC | $823.99 | 2019 | |
| Sun Pharmaceutical Industries INC. | $759.56 | 2019-2025 | Cequa |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $749.42 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $454.16 | 2019-2022 | |
| Alcon Vision LLC | $420.09 | 2019-2025 | Tryptyr |
| Oyster Point Pharma, INC. | $317.59 | 2022 | |
| Abbvie INC. | $260.17 | 2022-2023 | Durysta, Vuity |
| Eyevance Pharmaceuticals LLC | $158.93 | 2019 | |
| Ocular Therapeutix, INC. | $76.85 | 2020 | |
| Quidel Corporation | $76.29 | 2022 | |
| Biotissue Holdings INC. | $71.00 | 2019-2023 | |
| Sight Sciences, INC. | $42.33 | 2019 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Horizon Therapeutics Plc | $24.61 | 2022 | |
| Aerie Pharmaceuticals, INC. | $14.70 | 2020 | |
| Iridex Corporation | $13.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Rostov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.